ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Arteaga CL, Engelman JA (2014) Cancer Cell 25: 282-303 Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Lynch CC, Vargo-Gogola T, Martin MD, Fingleton B, Crawford HC, Matrisian LM (2007) Cancer Res 67: 6760-7 HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4. Strunk KE, Husted C, Miraglia LC, Sandahl M, Rearick WA, Hunter DM, Earp HS, Muraoka-Cook RS (2007) Cancer Res 67: 6582-90 Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice. Zeng F, Miyazawa T, Kloepfer LA, Harris RC (2014) Kidney Int 86: 538-47 Analysis of ErbB receptors in pulmonary carcinoid tumors. Rickman OB, Vohra PK, Sanyal B, Vrana JA, Aubry MC, Wigle DA, Thomas CF (2009) Clin Cancer Res 15: 3315-24 ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. Muraoka-Cook RS, Feng SM, Strunk KE, Earp HS (2008) J Mammary Gland Biol Neoplasia 13: 235-46 Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells. Zeng F, Xu J, Harris RC (2009) FASEB J 23: 1935-45 ERBB4 is over-expressed in human colon cancer and enhances cellular transformation. Williams CS, Bernard JK, Demory Beckler M, Almohazey D, Washington MK, Smith JJ, Frey MR (2015) Carcinogenesis 36: 710-8 The E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradation. Feng SM, Muraoka-Cook RS, Hunter D, Sandahl MA, Caskey LS, Miyazawa K, Atfi A, Earp HS (2009) Mol Cell Biol 29: 892-906 ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo. Muraoka-Cook RS, Sandahl MA, Strunk KE, Miraglia LC, Husted C, Hunter DM, Elenius K, Chodosh LA, Earp HS (2009) Mol Cell Biol 29: 4935-48 Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. Muraoka-Cook RS, Caskey LS, Sandahl MA, Hunter DM, Husted C, Strunk KE, Sartor CI, Rearick WA, McCall W, Sgagias MK, Cowan KH, Earp HS (2006) Mol Cell Biol 26: 6412-24 Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort. Giltnane JM, Moeder CB, Camp RL, Rimm DL (2009) Cancer 115: 2400-9 Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. Fukazawa R, Miller TA, Kuramochi Y, Frantz S, Kim YD, Marchionni MA, Kelly RA, Sawyer DB (2003) J Mol Cell Cardiol 35: 1473-9 The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium. Rokicki J, Das PM, Giltnane JM, Wansbury O, Rimm DL, Howard BA, Jones FE (2010) Mol Cancer 9: 150 Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation. Muraoka-Cook RS, Sandahl M, Hunter D, Miraglia L, Earp HS (2008) Mol Endocrinol 22: 2307-21 The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation. Feng SM, Sartor CI, Hunter D, Zhou H, Yang X, Caskey LS, Dy R, Muraoka-Cook RS, Earp HS (2007) Mol Endocrinol 21: 1861-76 Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo. Bernard JK, McCann SP, Bhardwaj V, Washington MK, Frey MR (2012) J Biol Chem 287: 39850-8 The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Muraoka-Cook RS, Sandahl M, Husted C, Hunter D, Miraglia L, Feng SM, Elenius K, Earp HS (2006) Mol Biol Cell 17: 4118-29 ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis. Zeng F, Zhang MZ, Singh AB, Zent R, Harris RC (2007) Mol Biol Cell 18: 4446-56 Targeting HER1/EGFR: a molecular approach to cancer therapy. Arteaga C (2003) Semin Oncol 30: 3-14 Embryo-uterine interactions via the neuregulin family of growth factors during implantation in the mouse. Brown N, Deb K, Paria BC, Das SK, Reese J (2004) Biol Reprod 71: 2003-11 Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle. Lebrasseur NK, Coté GM, Miller TA, Fielding RA, Sawyer DB (2003) Am J Physiol Cell Physiol 284: C1149-55 TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival. Hilliard VC, Frey MR, Dempsey PJ, Peek RM, Polk DB (2011) Am J Physiol Gastrointest Liver Physiol 301: G338-46 Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro. Cote GM, Miller TA, Lebrasseur NK, Kuramochi Y, Sawyer DB (2005) Exp Cell Res 311: 135-46 Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes. Pentassuglia L, Graf M, Lane H, Kuramochi Y, Cote G, Timolati F, Sawyer DB, Zuppinger C, Suter TM (2009) Exp Cell Res 315: 1302-12 The expression of neuregulin and erbB receptors in human skeletal muscle: effects of progressive resistance training. LeBrasseur NK, Mizer KC, Parkington JD, Sawyer DB, Fielding RA (2005) Eur J Appl Physiol 94: 371-5 ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response. Icli B, Bharti A, Pentassuglia L, Peng X, Sawyer DB (2012) Biochem Biophys Res Commun 418: 116-21 Cancer therapy-associated cardiotoxicity and signaling in the myocardium. Zuppinger C, Suter TM (2010) J Cardiovasc Pharmacol 56: 141-6
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.